• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷霉素-庆大霉素、磷霉素-头孢他啶、磷霉素-亚胺培南及头孢他啶-庆大霉素联合用药对耐头孢他啶铜绿假单胞菌的体外活性

In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.

作者信息

Pruekprasert Pornpimol, Tunyapanit Wanutsanun

机构信息

Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Thailand.

出版信息

Southeast Asian J Trop Med Public Health. 2005 Sep;36(5):1239-42.

PMID:16438151
Abstract

The effects of antimicrobial combinations against ceftazidime-resistant Pseudomonas aeruginosa strains isolated from hospitalized patients were investigated. Using the checkerboard titration method, combination of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin was synergistic against 4, 11, 38 and 39% of 22, 18, 29 and 18 strains tested respectively and additive effect of the combinations against the strains tested was 41, 33, 14 and 44%, respectively. Antagonistic effects against the isolates were noted when fosfomycin was combined with gentamicin (27%), ceftazidime (22%) and imipenem (7%). No antagonistic effect was observed in the ceftazidime-gentamicin combination.

摘要

研究了抗菌药物联合使用对从住院患者中分离出的耐头孢他啶铜绿假单胞菌菌株的影响。采用棋盘滴定法,磷霉素-庆大霉素、磷霉素-头孢他啶、磷霉素-亚胺培南和头孢他啶-庆大霉素联合使用分别对22株、18株、29株和18株测试菌株中的4%、11%、38%和39%具有协同作用,这些联合用药对测试菌株的相加作用分别为41%、33%、14%和44%。当磷霉素与庆大霉素(27%)、头孢他啶(22%)和亚胺培南(7%)联合使用时,对分离菌株有拮抗作用。头孢他啶-庆大霉素联合使用未观察到拮抗作用。

相似文献

1
In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.磷霉素-庆大霉素、磷霉素-头孢他啶、磷霉素-亚胺培南及头孢他啶-庆大霉素联合用药对耐头孢他啶铜绿假单胞菌的体外活性
Southeast Asian J Trop Med Public Health. 2005 Sep;36(5):1239-42.
2
In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.磷霉素与头孢他啶、亚胺培南、阿米卡星及环丙沙星联合对铜绿假单胞菌的体外活性
Eur J Clin Microbiol Infect Dis. 1997 Feb;16(2):159-62. doi: 10.1007/BF01709477.
3
In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.耐头孢菌素革兰氏阴性菌的体外药敏模式
J Med Assoc Thai. 2008 Oct;91 Suppl 3:S21-7.
4
In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.关于磷霉素单独及与其他抗生素联合作用于铜绿假单胞菌和粘质沙雷氏菌的体外研究。
Arzneimittelforschung. 1980;30(8):1247-9.
5
In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases.黏菌素或舒巴坦与磷霉素或亚胺培南联合应用对产OXA-23碳青霉烯酶的耐碳青霉烯鲍曼不动杆菌临床分离株的体外活性。
Southeast Asian J Trop Med Public Health. 2011 Jul;42(4):890-900.
6
Comparison of imipenem and five other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa.亚胺培南与其他五种抗铜绿假单胞菌药物对庆大霉素敏感和耐药铜绿假单胞菌的比较。
Chemotherapy. 1995 Sep-Oct;41(5):334-6. doi: 10.1159/000239364.
7
[In vitro action of fosfomycin combined with rifampicin, pefloxacin and imipenem on staphylococci (checkerboard method in a liquid medium)].磷霉素与利福平、培氟沙星及亚胺培南联合对葡萄球菌的体外作用(液体培养基棋盘法)
Pathol Biol (Paris). 1987 Feb;35(2):153-7.
8
In vitro effect of subinhibitory concentrations of ceftazidime and meropenem on the serum sensitivity of Pseudomonas aeruginosa strains.亚抑菌浓度的头孢他啶和美罗培南对铜绿假单胞菌菌株血清敏感性的体外效应
Coll Antropol. 2007 Mar;31(1):221-5.
9
In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.环丙沙星与氨基糖苷类药物对多重耐药铜绿假单胞菌的体外协同作用
Pak J Pharm Sci. 2013 Sep;26(5):1041-4.
10
Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).头孢吡肟对北美医院耐头孢他啶革兰阴性临床菌株的抗菌活性:哨兵抗菌监测计划(1998 - 2004年)报告
Diagn Microbiol Infect Dis. 2006 Sep;56(1):63-8. doi: 10.1016/j.diagmicrobio.2006.02.009. Epub 2006 May 2.

引用本文的文献

1
Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies.磷霉素作为全身感染管理的联合用药。对其体外和体内研究协同特性的系统评价。
Antibiotics (Basel). 2020 Aug 10;9(8):500. doi: 10.3390/antibiotics9080500.
2
Frequency of spontaneous resistance to fosfomycin combined with different antibiotics in Pseudomonas aeruginosa.铜绿假单胞菌对磷霉素与不同抗生素联合用药的自发耐药频率
Antimicrob Agents Chemother. 2010 Nov;54(11):4948-9. doi: 10.1128/AAC.00415-10. Epub 2010 Aug 16.
3
Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria.
磷霉素与其他抗生素对革兰氏阳性菌和革兰氏阴性菌的协同作用。
Eur J Clin Pharmacol. 2010 Apr;66(4):359-68. doi: 10.1007/s00228-010-0794-5. Epub 2010 Feb 26.